Rubella Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020

Transparency Market Research Reports incorporated a definite business overview and investigation inclines on “Rubella Diagnostic Testing Market”. This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. Rubella or German measles is a contagious and acute viral infection caused by the rubella virus. Generally, rubella infection occurs most often in young adults and children. While the rubella infection is typically mild in children, this disease has serious consequences in pregnant women causing congenital defects and fetal death.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/rubella-diagnostic-testing-market.html

Some of the diagnostic testing techniques usually adopted for the diagnosis of rubella are as follows:

Clinical evaluation

Serological testing

Immunoassays

Monoclonal antibodies

Latex slide agglutination test

Flow cytometry

At present, there is no standard drug therapy available for treating rubella. However, MMR vaccine, which is an immunization vaccine, is administered to children for protecting against measles, mumps, and rubella. The goals of medications given to the patients are only to prevent complications and to reduce morbidity.

In terms of geography, Europe is the leading market in rubella diagnostic testing market due to the high susceptibility to rubella. It has been stated that, as of 2004, the U.S. was declared free of rubella and the transmission of the rubella virus was halted across the regions of the Americas in 2009. Furthermore, on January 2014, the PAHO (Pan American Health Organization) and WHO (World Health Organization) declared the Latin American country, Colombia free of rubella. However, it has been observed, epidemics of rubella still occur in developing regions such as South East Asia and Africa, where the vaccine for rubella is not available or accessible. The...